Research ArticleOpen AccessGoogle Scholar indexed
Evaluation of Viral Hepatitis B Treatment in Pointe-Noire in 2016
Department of Gastroenterology, Loandjili General Hospital, Pointe-Noire, Congo-Brazzaville
Faculty of Health Sciences, Department of Public Health, Marien Ngouabi University, Brazzaville, Congo
Department of Gastroenterology, University Hospital of Brazzaville, Brazzaville, Congo
Department of Gastroenterology, University Hospital of Brazzaville, Brazzaville, Congo
Department of Gastroenterology, University Hospital of Brazzaville, Brazzaville, Congo
Department of Gastroenterology, Loandjili General Hospital, Pointe-Noire, Congo-Brazzaville
Department of Gastroenterology, University Hospital of Brazzaville, Brazzaville, Congo
Department of Gastroenterology, University Hospital of Brazzaville, Brazzaville, Congo
- 1 Department of Gastroenterology, Loandjili General Hospital, Pointe-Noire, Congo-Brazzaville
- 2 Faculty of Health Sciences, Department of Public Health, Marien Ngouabi University, Brazzaville, Congo
- 3 Department of Gastroenterology, University Hospital of Brazzaville, Brazzaville, Congo
- 4 Department of Gastroenterology, University Hospital of Brazzaville, Brazzaville, Congo
- 5 Department of Gastroenterology, University Hospital of Brazzaville, Brazzaville, Congo
- 6 Department of Gastroenterology, Loandjili General Hospital, Pointe-Noire, Congo-Brazzaville
- 7 Department of Gastroenterology, University Hospital of Brazzaville, Brazzaville, Congo
- 8 Department of Gastroenterology, University Hospital of Brazzaville, Brazzaville, Congo
International Journal of Clinical Medicine·Volume 09 (2018)·Pages 513–519·Published 4 June 2018·DOI10.4236/ijcm.2018.96044
Copy link · social · email
Abstract
Prevalence of hepatitis B in Pointe-Noire is 23%. The objective of this study was to evaluate the level of therapeutic management of patients with hepatitis B in Pointe-Noire. Methods: A retrospective, cross-sectional, descriptive and analytical study. Results: 302 patients included: 217 (72%) men and 85 (28%) women of median age 40 years. The viral load was measured in 140 (46%) patients and in 162 (54%), the viral load was not measured. Their distribution according to the viremia was as follows: 0 - 1 log = 1 (0.7%) patients; 1.5 to 2 log = 23 (16%) patients; 2.5 to 3 log = 49 (35%) patients; >3log = 55 (39%) patients. Of the 302 patients included, 36 (11%) patients were treated with antivirals and 253 (83%) patients were not. Conclusion: The number of patients treated for chronic viral hepatitis B was low. Our results show interest for improved preventive and curative management of hepatitis B in Congo in order to reduce the existing high prevalence.
KeywordsAccessCongoHepatitis BPointe-NoireTreatment
- WHO (2017) Global Hepatitis Report. http://www.who.int/hepatitis/publications/global-hepatitis-r eport2017-executive-summary/en/
- OMS (2017) Hepatitis B. Aide-mémoire N°204. Juillet 2017.
- Denis, F. and Maniez, M. (2001) Le virus de l’hépatite B. Cahier de formation biologie médicale, No. 21, 40-41.
- Pol, S. (2010) L’hépatite B demeure un problème de santé publique en France. Archives de Pédiatrie, 17, H1-H5. https://doi.org/10.1016/S0929-693X(10)70007-5
- Denis, F., Adjide, C.C., Rogez, S., Delpeyroux, C., Rogez, J.P. and Weinbreck, P. (1997) Séroprévalence des marqueurs des virus des hépatites B, C et D chez 500 patients infectés par le virus de l’immunodéficience humaine. Pathologie et biologie, 45, 701-708.
- Bradai, S. and Taleb, M. (2014) Les hépatites virales—Exploration d’une base de données exhaustive du CHU de Sidi Bel Abbès, Algérie. Revue d’épidémiologie et de Santé Publique, 6, S232. https://doi.org/10.1016/j.respe.2014.06.195
- Migliani, R., Rousset, D., Rakoto-Andrianarivelo, M., Rabarijaona, L., Ratsitorahina, M., Rajaonarivony, V., et al. (2000) Infection par le virus de l’hépatite B: Un problème de santé publique à Madagascar. Arch Inst Pasteur Madagascar, 66, 50-54.
- Pourette, D. and Enel, C. (2014) Représentations et vécu de l’hépatite B de patients subsahariens en Côte d’Ivoire et en France. Santé publique, 26, 869-878. https://doi.org/10.3917/spub.146.0869
- Ntagirabiri, R., Munezero, B., Kaze, H., Ndirahisha, E. and Manirakiza, S. (2015) Incidence du carcinome hépatocellulaire lors de l’infection chronique par le virus de l’hépatite B. Pan African Medical Journal, 20.
- Bossali, F., Taty-Taty, R., Houssissa, P., Nsuele, W., Lingouala, L.G., Ontsira, E.N. and Obengui (2012) Séroprévalence de la co-infection hépatite B, hépatite C et VIH chez des femmes accouchées à la maternité de l’hôpital Adolphe Sicé de Pointe-Noire en 2010. Journal Africain d’Hépato-Gastroentérologie, 6, 315-319. https://doi.org/10.1007/s12157-012-0424-1
- Atipo Ibara, B.I., Itoua-Ngaporo, A.N., Dzia-Lepfoundzou, A., Ahoui-Apendi, C., Deby-Gassaye, Bossali, F., Ngami, S.R., Ennaji, Boumba, A. and Ibara, J.R. (2015) Virus de l’hépatite B au Congo-Brazzaville: Séroprévalence et biodiversité génétique chez les donneurs de sang en zone hyper endémique. Journal Africain de Hépato-Gastroentérologie, 9, 127-131.
- Deby, G., Malanda, C.B., Bossali, F., Atipo-Ibara, B.I., Bokilo-Dzia, A., Ahoui-Apendi, C., et al. (2015) Seroprévalence des marqueurs des virus des hepatites B et C chez le personnel soignant du CHU de Brazzaville. Journal Africain de Hépato-Gastroentérologie, 9, 179-183.